Hudson Valley Investment Advisors Inc Bristol Myers Squibb CO Transaction History
Hudson Valley Investment Advisors Inc
- $912 Million
- Q2 2025
A detailed history of Hudson Valley Investment Advisors Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hudson Valley Investment Advisors Inc holds 5,989 shares of BMY stock, worth $275,074. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,989
Previous 10,209
41.34%
Holding current value
$275,074
Previous $622,000
55.47%
% of portfolio
0.03%
Previous 0.07%
Shares
32 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.58BCall Options Held
26.1MPut Options Held
23.8M-
Vanguard Group Inc Valley Forge, PA195MShares$8.95 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.29 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.96 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.36 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.05 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...